Overview Financials News + Filings Key Docs Ownership Insiders
|
| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| NDX Laboratories | 118.8 | 126.2 | 127.4 | 126.5 | 121.4 | | | |
| Laboratory Operating Income | 25.0 | 23.5 | 25.5 | 22.1 | 23.2 | | | |
| Keller Group | 24.2 | 26.0 | 23.8 | 4.9 | | | | |
| Green Dental Laboratory | 19.2 | 20.7 | 19.9 | 18.8 | 14.5 | | | |
| Total revenues | 161.2 | 171.7 | 170.4 | 150.1 | 135.8 | 111.8 | 99.3 | 95.2 |
| Revenue growth [+] | -6.1% | 0.8% | 13.5% | 10.5% | 21.6% | 12.6% | 4.3% | 11.0% |
| NDX Laboratories | -5.9% | -0.9% | 0.7% | 4.3% | | | | |
| Laboratory Operating Income | 6.2% | -7.7% | 15.2% | -4.5% | | | | |
| Keller Group | -6.7% | 9.0% | 390.2% | | | | | |
| Green Dental Laboratory | -7.5% | 4.4% | 5.5% | 29.7% | | | | |
| Cost of goods sold | 93.1 | 102.2 | 97.7 | 88.3 | 78.4 | 67.0 | 59.5 | 56.2 |
| Gross profit | 68.1 | 69.5 | 72.6 | 61.8 | 57.5 | 44.8 | 39.7 | 39.0 |
| Gross margin | 42.2% | 40.5% | 42.6% | 41.2% | 42.3% | 40.1% | 40.0% | 41.0% |
| Selling, general and administrative | 55.8 | 58.6 | 58.6 | 50.1 | 44.7 | 35.8 | 30.1 | 29.3 |
| EBITDA [+] | 18.1 | 16.9 | 19.4 | 16.6 | 16.7 | 12.2 | 12.0 | 11.8 |
| EBITDA growth | 7.3% | -12.8% | 17.2% | -0.7% | 36.9% | 1.3% | 2.2% | -7.6% |
| EBITDA margin | 11.3% | 9.9% | 11.4% | 11.0% | 12.3% | 10.9% | 12.1% | 12.4% |
| Depreciation and amortization | 5.8 | 6.0 | 5.3 | 4.8 | 3.9 | 3.1 | 2.4 | 2.1 |
| EBIT [+] | 12.3 | 10.9 | 14.1 | 11.7 | 12.7 | 9.0 | 9.6 | 9.7 |
| EBIT growth | 13.0% | -22.5% | 19.8% | -7.8% | 40.8% | -6.2% | -0.2% | -1.6% |
| EBIT margin | 7.6% | 6.4% | 8.3% | 7.8% | 9.4% | 8.1% | 9.7% | 10.1% |
| Non-recurring items [+] | 0.3 | 7.0 | | | | | | |
| Asset impairment | 0.3 | 7.0 | | | | | | |
| Interest expense, net [+] | 1.3 | 2.1 | 2.8 | 1.5 | 0.7 | 0.0 | 0.0 | -0.1 |
| Interest expense | 1.3 | 2.1 | 2.8 | 1.5 | 0.7 | 0.0 | | |
| Interest income | | | | | | | 0.0 | 0.1 |
| Other income (expense), net | -0.7 | -0.7 | -0.8 | -0.8 | -0.6 | -0.4 | -0.3 | -0.2 |
| Pre-tax income | 10.1 | 1.1 | 10.5 | 9.4 | 11.4 | 8.6 | 9.4 | 9.5 |
| Income taxes | 4.2 | 2.0 | 3.9 | 3.7 | 4.3 | 3.4 | 3.6 | 3.6 |
| Tax rate | 41.6% | 180.1% | 36.8% | 38.9% | 37.9% | 40.0% | 38.5% | 38.3% |
| Net income | 5.9 | -0.9 | 6.6 | 5.8 | 7.1 | 5.2 | 5.8 | 5.9 |
| Net margin | 3.6% | -0.5% | 3.9% | 3.8% | 5.2% | 4.6% | 5.8% | 6.2% |
| |
| Basic EPS [+] | $1.03 | ($0.16) | $1.20 | $1.05 | $1.33 | $0.99 | $1.12 | $1.13 |
| Growth | -758.9% | -113.0% | 13.8% | -20.9% | 33.6% | -11.4% | -1.1% | -34.0% |
| Diluted EPS [+] | $1.02 | ($0.16) | $1.17 | $1.01 | $1.27 | $0.94 | $1.10 | $1.10 |
| Growth | -755.0% | -113.3% | 16.3% | -20.6% | 34.1% | -14.5% | 0.0% | -34.2% |
| |
| Shares outstanding (basic) [+] | 5.7 | 5.6 | 5.5 | 5.5 | 5.3 | 5.2 | 5.1 | 5.2 |
| Growth | 1.7% | 1.6% | 1.0% | 2.8% | 2.8% | 1.1% | -1.1% | 49.1% |
| Shares outstanding (diluted) [+] | 5.8 | 5.6 | 5.7 | 5.7 | 5.6 | 5.5 | 5.2 | 5.3 |
| Growth | 2.3% | -0.6% | -1.2% | 2.3% | 2.5% | 4.8% | -2.1% | 49.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|